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Background: Offspring of consanguineous couples are at increased risk of congenital disorders. The risk increases
as parents are more closely related. Individuals that have the same degree of relatedness according to their
pedigree, show variable genomic kinship coefficients. To investigate whether we can differentiate between couples
with high- and low risk for offspring with congenital disorders, we have compared the genomic kinship coefficient
of consanguineous parents with a child affected with an autosomal recessive disorder with that of consanguineous
parents with only healthy children, corrected for the degree of pedigree relatedness.
Methods: 151 consanguineous couples (73 cases and 78 controls) from 10 different ethnic backgrounds were
genotyped on the Affymetrix platform and passed quality control checks. After pruning SNPs in linkage
disequilibrium, 57,358 SNPs remained. Kinship coefficients were calculated using three different toolsets: PLINK, King
and IBDelphi, yielding five different estimates (IBDelphi, PLINK (all), PLINK (by population), King robust (all) and King
homo (by population)). We performed a one-sided Mann Whitney test to investigate whether the median relative
difference regarding observed and expected kinship coefficients is bigger for cases than for controls. Furthermore,
we fitted a mixed effects linear model to correct for a possible population effect.
Results: Although the estimated degrees of genomic relatedness with the different toolsets show substantial
variability, correlation measures between the different estimators demonstrated moderate to strong correlations.
Controls have higher point estimates for genomic kinship coefficients. The one-sided Mann Whitney test did not
show any evidence for a higher median relative difference for cases compared to controls. Neither did the
regression analysis exhibit a positive association between case–control status and genomic kinship coefficient.
Conclusions: In this case–control setting, in which we compared consanguineous couples corrected for degree of
pedigree relatedness, a higher degree of genomic relatedness was not significantly associated with a higher likelihood
of having an affected child. Further translational research should focus on which parts of the genome and which
pathogenic mutations couples are sharing. Looking at relatedness coefficients by determining genome-wide SNPs
does not seem to be an effective measure for prospective risk assessment in consanguineous parents.
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Consanguineous marriages – unions between relatives
up to the fifth degree – occur in many different parts of
the world and are the preferred type of marriage within
several populations due to cultural and socioeconomic
advantages [1]. Consanguinity is associated with an in-
crease in congenital/hereditary disorders in offspring, in
particular autosomal recessive (AR) disorders. An esti-
mated excess of 1.7-2.8 % in morbidity and 3.5 % in mor-
tality has been observed among the offspring of first
cousins compared to the offspring of non-consanguineous
parents [2]. The risk is dependent on the inbreeding coef-
ficient and the presence of a pathogenic mutation passed
on by a common ancestor. Given the estimated excess risk
of 1.7-2.8 %, it can be concluded that four times those per-
centages (6.8-11.2 %) of all first-cousin couples are at high
risk of 25 % (or more if they are a carrier couple for more
than one AR disorder) for each of their children to be af-
fected by the associated disorder [1, 3]. The risk of being a
carrier couple rises substantially with evidence of a family
history for a given genetic disorder [2], but often no
family history is known and yet the risk is increased.
This makes personalized risk assessment difficult, and
discriminating between high-risk- (25 % or more) and
low-risk couples (comparable to the risk for the general
population) often impossible.
In order to provide the best possible risk information
and genetic counselling for consanguineous couples be-
fore pregnancy, health care providers generally aim to
estimate the total risk by both calculating the inbreeding
coefficient based on the pedigree and by taking a family his-
tory. As mentioned earlier, calculating the actual inbreeding
coefficient is difficult, due to complex undocumented ge-
nealogies and the fact that DNA identical-by-descent (IBD)
between consanguineous partners is subject to variation be-
cause of stochastic events during meiosis [3].
In theory, an increase in the proportion of DNA IBD
sharing will increase the chance of the presence of
pathogenic alleles in both parents and consequently the
risk of having children affected by autosomal recessive
disorders. In the present study, whose methodology was
published earlier [3], the following hypothesis was tested:
in a case–control setting, consanguineous parents with a
child affected by an autosomal recessive disorder and with-
out a family history of AR disorder have more DNA IBD
than similarly related consanguineous parents with only
healthy children. If the hypothesis can be confirmed, know-
ing the genomic proportion of DNA IBD may be helpful to
assess risk more precisely in consanguineous couples.
Methods
Participants
Information on the in- and exclusion of couples and the
number of participants is presented in Table 1. The aimwas to include 100 consanguineous couples (cases)
with one or more children affected by an autosomal re-
cessive disorder and 100 consanguineous couples (con-
trols) with a family relation comparable to the cases
and with only healthy children (at least three). Infor-
mation on the identity of all first-degree- to third-
degree family members of both partners of the couples
was obtained as far as this was known to the couple.
Cases were excluded if another individual in the family
affected by the same disorder was known. Cases were
not only included when molecular data were available,
but also if the nature of the AR disorder was beyond
doubt because of clinical or biochemical confirmation
(which was the case in 7/73 cases). AR disorders in-
cluded ranged from rare to extremely rare. Further details
on the methods of ascertainment have been described
earlier [3]. It was attempted to have equal numbers of
case- and control couples of every ethnic background.
Moreover, similar distributions of pedigree relatedness
among both the case couples and the control couples were
aimed for. There were ten cases where we had a case- and
control couple from the same family. The 168 couples
originated from 10 different populations (Tunisia, Saudi
Arabia, Turkey, Jordan, Morocco, Pakistan, Iraq, Iran,
Afghanistan, the Netherlands). Approval for the study was
obtained from the Medical Ethics Committee of the VU
University Medical Center (the Netherlands), le comité de
Protection des Personnes de l’hôpital Charles Nicolle
(Tunisia), the Research Ethics Committee (REC) at
KFSHRC (Saudi-Arabia), the Clinical Trials Ethical Com-
mittee at Istanbul Medical Faculty of the Istanbul Univer-
sity (Turkey) and the IRB committee of Jordan University
Hospital (Jordan).
Sample preparation, genotyping and quality control
For the couples other than the Saudi Arabian couples,
DNA was extracted from the individual’s saliva samples
according to standard procedures; for 54 case couples,
DNA extracted from blood was available. A total of 66
and 70 non-Saudi case- and control couples respect-
ively were genotyped according to manufacturer’s
protocol using Affymetrix 6.0 SNP arrays. The Saudi
Arabian couples were subjected to genotyping using
Affymetrix 250 K arrays (6 individuals) and Affymetrix
Axiom arrays (48 individuals), after DNA extraction
from whole blood (See Additional file 1: Table S1).
PLINK was used to perform post-genotyping quality
control [4]. Individuals with a genotyping rate of <95 %
were excluded. All genotype data were merged for
overall analysis; Tunisian, Saudi, and Turkish couples
were also merged into separate files for further analysis
for each population. Duplicated SNPs were removed
and only SNPs were included with a genotype call rate
of >95 %. Further quality control included removal of
Table 1 In- and exclusion of couples
Population Case couples Case individuals Control couples Control individuals
TUN Considered eligible 50 102
Reliable pedigree and suitable sample: 50 52
Blood 100
Saliva 104
Genotype
Remaining after DNA quality control 50 52
Remaining after data quality control 47 49
SAU Considered eligible 14 14
Reliable pedigree and suitable sample: 13 14
Blood
Saliva
Genotype 26 28
Remaining after DNA quality control 13 14
Remaining after data quality control 11 12
TUR Considered eligible 9 12
Reliable pedigree and suitable sample: 9 12
Blood 4
Saliva 14 24
Genotype
Remaining after DNA quality control 7 10
Remaining after data quality control 6 10
MOR Considered eligible 4 3
Reliable pedigree and suitable sample: 3 2
Blood
Saliva 6 4
Genotype
Remaining after DNA quality control 3 2
Remaining after data quality control 3 1
JOR Considered eligible 7 7
Reliable pedigree and suitable sample: 2 3
Blood
Saliva 4 6
Genotype
Remaining after DNA quality control 2 3
Remaining after data quality control 2 3
PAK Considered eligible 16 16
Reliable pedigree and suitable sample: 1 1
Blood
Saliva 2 2
Genotype
Remaining after DNA quality control 1 1
Remaining after data quality control 1 1
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Table 1 In- and exclusion of couples (Continued)
NLD Considered eligible 1 2
Reliable pedigree and suitable sample: 1 1
Blood
Saliva 2 2
Genotype
Remaining after DNA quality control 1 1
Remaining after data quality control 1 1
AFG Considered eligible 1
Reliable pedigree and suitable sample: 1
Blood
Saliva 2
Genotype
Remaining after DNA quality control 1
Remaining after data quality control 1
IRQ Considered eligible 2 2
Reliable pedigree and suitable sample: 1 1
Blood
Saliva 2 2
Genotype
Remaining after DNA quality control 0 1
Remaining after data quality control 0 1
IRN Considered eligible 1
Reliable pedigree and suitable sample: 1
Blood 2
Saliva
Genotype
Remaining after DNA quality control 1
Remaining after data quality control 1
TOTAL Considered eligible 105 158
Reliable pedigree and suitable sample 82 86
Remaining after DNA quality control 79 84
Remaining after data quality control 73 78
TUN Tunisia, SAU Saudi Arabia, TUR Turkey, MOR Morocco, JOR Jordan, PAK Pakistan, NLD the Netherlands, AFG Afghanistan, IRQ Iraq, IRN Iran)
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After quality control, 73 case couples and 78 control
couples genotyped for 143,512 markers were available
for the analysis (see Table 1). To obtain a pruned subset
of markers with low linkage disequilibrium, the PLINK-
indep-pairwise option was used with parameters 50 5
1.5. (57,358 SNPs remaining). Multidimensional scaling
was performed to analyse the population substructuring
by using the PLINK MDS plot option. Results were en-
tered in the statistical package R version 3.0.1 (http://
www.r-project.org/) and SPSS version 20 for Windows
[5]. The MDS plot was inspected for population cluster-
ing and case/control matching.Analysis of pairwise relatedness
A kinship coefficient based on the pedigree reported for
each couple was calculated according to the method as
described by Wright [6].
Although pairwise coefficients of relatedness in gen-
omic data can be calculated based on known allele fre-
quencies in a population, these allele frequencies are
frequently not known and often calculated from the
sample by estimators of relatedness [7]. Lack of homo-
geneity of the sample or sampling errors can lead to
false estimates [7, 8]. Since in some populations, individ-
uals are genetically more similar than in other countries,
to estimate the genomic pairwise relatedness of our
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IBDelphi) to account for the population stratification as
well as for the inbreeding in our sample. Moreover, we es-
timated the relationship coefficients from the whole set of
samples (overall analysis), as well as from separate sets
containing only couples from one population (population
subgroup analysis). This latter analysis was performed only
for the Tunisian, Saudi and Turkish couples, given the
small sample sizes from the other populations.
PLINK uses a method-of-moments approach where
the probability of sharing 0, 1 or 2 SNPs IBD is calcu-
lated. The total proportion of SNPs IBD is calculated
based on the estimated allele frequency of all SNPs and
assumes homogeneity [4]. King uses the same approach,
and offers two different methods: King homo, which as-
sumes homogeneity of the sample, and King robust,
which provides robust relationship inference allowing
for heterogeneity of the sample by a robust approach
that accounts for population stratification [8, 9]. Finally,
IBDelphi is an algorithm that analyses raw data of high-
density SNP genotypes from a consanguineous couple
by looking for homozygous regions of over 0.5 Mb in
both genomes that lack SNPs that exclude IBD [10].
In PLINK, pairwise relatedness between partners of
each couple was calculated with the –genome –rel-check
command in PLINK. In King, the pruned subset of SNPs
was used to calculate pairwise IBD through the kinship
parameter (for the overall analysis) and homo parameter
(for the population subgroup analysis). Finally, individual
genotype files were entered pairwise in IBDelphi, produ-
cing IBD measures. All estimates of pairwise related-
ness (pedigree, PLINK, King and IBDelphi) were
entered in the statistical package R and SPSS version
20. Pearson’s correlation coefficients were calculated
for correlations between the different estimates. Rgen
represents the relatedness as derived from the geno-
type, while Rped was calculated based on the pedigree
information reported.
The ratio R = (Rgen-Rped)/Rped was used as a measure
of the degree of similarity between Rgen and Rped, with
Rgen being the observed measure of pairwise relatedness
(resulting from our analyses by the four different ap-
proaches) and Rped the kinship coefficient between the
parents of a child based on the pedigree. If, for a couple,
Rped is higher (lower) than Rgen, R is negative (positive).
By dividing the difference by Rped, we consider the rela-
tive differences. The possible influence of population was
ignored first, and the alternative hypothesis was tested that
the median of the distribution of ratio R of cases (couples
with affected children) is higher than the median of the
distribution of controls (couples with only healthy chil-
dren) with the one-sided non-parametric Mann Whitney
test at level 0.05. Since most (96 of the 151 couples) cou-
ples come from Tunisia, they were subsequently selectedto filter out a possible population effect, and the same test
was performed based on these selected data. The analyses
were also done separately for the first cousin couples
(based on pedigree) as they are the most predominant
consanguineous couples who seek genetic counselling.
Next, a mixed effects linear model was assumed. The
outcome variable in the model is equal to ratio R, the
covariates consist of an intercept, the fixed effect 0–1
variable “whether the couple has an affected child (co-
variate equals 1) or not (covariate equals 0)” (i.e. case or
control), and a random effect “population”. The popula-
tion effect on the association between the outcome vari-
able R and the case–control status was investigated and
the one-sided alternative hypothesis was tested regarding
whether the regression parameter for case–control status
was positive, corrected for a possible population effect if
“population” is a confounder.
Results
Seventy-three case- and 78 control couples from 10
different populations were analysed (Table 1;
Additional file 1: Table S1). Sixty-five of the 73 case
couples had a child with an autosomal recessive dis-
order that was diagnosed by molecular testing, two
case couples had a child that was diagnosed by bio-
chemical testing, and the remaining six case couples
had a child with a clinical diagnosis for an AR disorder.
The respective AR disorders are presented as Supple-
mentary Information. Control couples had on average
4.2 children (SD = 1.6), ranging from three to 11.
Substructuring within the different ethnicities
In Fig. 1 two components resulting from within-group
multidimensional scaling analysis of all individuals are
plotted against each other in a scatter plot. As expected,
evidence of substructuring within the different ethnici-
ties is present, with each population distinguishable from
the others. Saudi individuals are observed to cluster sep-
arately from the other populations in the lower right
corner of the figure as a result of using a different
marker set for the genotyping. To explore comparability
of cases and controls, they were plotted separately
(Fig. 2). This shows consistent clustering by population,
with an apparent overlap of cases and controls.
Relationship inference estimates
The estimated degrees of relatedness show a substantial
variability between the different estimators (Table 2).
PLINK (all) kinship coefficients estimates resulted in a
mean for case couples of 0.110 (SD = 0.06), the mean for
control couples was 0.108 (SD = 0.05). King robust (all)
estimates for all samples are lowest (cases: mean = 0.039
(SD = 0.035) vs. controls: mean = 0.050 (SD =0.031)). In
contrast to our hypothesis, controls show higher point
a b
Fig. 1 a shows an MDS two-dimensional plot of all individuals in the sample, showing separate clustering of Saudi Arabian individuals (lower right
corner). b: enhancement of upper left corner of Fig. 1a
Fig. 2 MDS two-dimensional plot of all individuals in the sample. Cases indicated with green dots, controls with blue dots
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Table 2 Mean and standard deviation of pedigree-based
relatedness coefficient and relatedness inference estimates
for different estimators
Mean (standard deviation)
Case Control
Pedigree 0.110 (0.058) 0.108 (0.049)
PLINK (all) 0.151 (0.064) 0.164 (0.054)
King robust (all) 0.039 (0.035) 0.050 (0.031)
PLINK (by population) 0.126 (0.063) 0.141 (0.051)
King homo. (by population) 0.054 (0.034) 0.062 (0.030)
IBDelphi 0.121 (0.059) 0.133 (0.053)
all whole sample; by population separate estimates for Tunisian, Saudi and
Turkish couples
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differences in level of the estimate, correlation measures
between the different estimators show moderate to
strong correlations. Pearson’s correlation coefficients
were greater or equal to r = +0.739, p < 0.001 (Table 3).
Genomic estimates compared to pedigree-based
estimates
The results of the genomic estimates of the estimators
were plotted against the relatedness coefficient based
on the pedigree (Fig. 3). As expected, higher pedigree-
based estimates, on average, correlate with higher gen-
omic estimates. In a proportion of couples, genomic
relatedness is much increased compared to the ex-
pected relatedness based on the pedigree, resulting in a
skewed distribution of relatedness towards higher
values, which can be explained by hidden consanguin-
eous loops.
Comparing estimates of IBD in cases to IBD in controls
The PLINK (all) mean and median value of the genetic
difference ratio R in the sample of couples with affected
children are equal to 0.638 and 0.454, respectively,
whereas these values unexpectedly increase to 0.892 and
0.514 in the sample of couples with unaffected children.
Our hypothesis was thus not confirmed. The consider-
able difference between the means and the medians are
caused by a few couples with high R-values (i.e. R ≥ 3).
This was the case in 4 couples in the PLINK (all)Table 3 Pearson’s correlation coefficient between estimators
IBDelphi PLINK (all) Kin
PLINK (all) .947 1 .88
King robust (all) .739 .880 1
PLINK (by pop.) .926 .963 .81
King homo (by pop.) .919 .962 .83
IBDelphi 1 .947 .73
P-values were all <0.001. all whole sample; by pop. separate estimates for Tunisian,analysis. For the other estimators this involved: 0 couples
(King robust (all)), 2 couples (PLINK (by population)), 1
couple (King homo (by population)) and 3 couples
(IBDelphi).
For ten case couples, a control couple from the same
family was available. The association between their R-
values was computed and considered by making scatter
plots. Since no association was seen, the R-values of case
couples and control couples within a family are assumed
to be independent in the further analysis. The one-sided
Mann Whitney test based on the whole data set gave a
p-value of 0.907. The other three methods for estimating
DNA IBD as well as the separate analyses for first cousin
couples yielded similar p-values (Table 4). Based on this
test, it cannot be concluded that couples with affected
children are genetically more similar than expected,
based on their kinship relatedness, than couples without
affected children. Next, the parameters in the mixed ef-
fects linear model were estimated. In all models, “popu-
lation” seems not to be a confounder and was left out of
the model (the estimated standard deviation was very
small compared to the estimated standard deviation for
the measurement error in the model). Also including the
covariate “Rgen” into the linear model gave a better fit,
but the association between the variable “case–control
status” and the outcome variable hardly changed. This
was expected due to the design of the study. It was
tested whether the regression parameter for the covari-
ate case–control status was significantly bigger than zero
in the linear model. In the latter analysis, several influ-
ence points were left out. With PLINK (all) measures,
the regression parameter was estimated as −0.028 and
the alternative hypothesis that the regression parameter
is positive was not rejected. Estimates and p-values for
the other methods can be found in Table 4. The conclu-
sion still holds true: it cannot be concluded that couples
with affected children have more DNA IBD than couples
with only healthy children.
Another way of accounting for a possible population
effect is by selecting individuals from a single population
and performing the Mann Whitney test based on this
subset only. For the Tunisian data only (96 couples),
PLINK (by population), King homo (by population) and
IBDelphi, a Mann Whitney test was performedg robust (all) PLINK (by pop.) King homo (by pop.)
0 .963 .962
.814 .831
4 1 .964
1 .964 1
9 .926 .919
Saudi and Turkish couples
Fig. 3 Pedigree kinship coefficient plotted against kinship coefficient estimates of different estimators. Cases indicated with green dots, controls
with blue dots.
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Table 4 Results of Mann Whitney test and mixed effects linear model for ratio R
Mean / Median Mann Whitney test Mixed effects model
Case Control p-value β p-value
PLINK (all) All couples 0.276 / 0.313 0.347 / 0.338 0.907 −0.028 0.625
1st cousinsa 0.290 / 0.320 0.410 / 0.404 0.980
King robust (all) All couples −0.615 / -0.595 −0.462 / -0.534 0.990 −0.152 0.992
1st cousinsa −0.580 / -0.550 −0.520 / -0.510 0.950
PLINK (by population) All couples 0.209 / 0.145 0.594 / 0.233 0.991 −0.157 0.965
1st cousinsa 0.080 / 0.130 0.200 / 0.180 0.950
King homo (by population) All couples −0.506 / -0.490 −0.341 / -0.428 0.996 −0.086 0.980
1st cousinsa −0.490 / -0.474 −0.430 / -0.428 0.940
IBDelphi All couples 0.278 / 0.192 0.479 / 0.252 0.854 −0.085 0.834
1st cousinsa 0.058 / 0.057 0.160 / 0.160 0.950
a Based on pedigree
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median of ratio R equal respectively 0.132 and 0.073 for
the couples with an affected child and 0.510 and 0.182
for those without an affected child. The couples without
an affected child show, on average, a higher genomic
kinship relatedness than expected compared to the cou-
ples with an affected child. The p-value of the one-sided
Mann Whitney test now equals 0.990. For the results of
the other estimators, see Table 5. So, by restricting the
analysis to Tunisian couples, it cannot be concluded that
couples from Tunisia with an affected child have more
DNA IBD than expected based on their kinship related-
ness than couples from Tunisia without affected children.
The values ratio R mean and median rather show the re-
verse of what was expected. The three other methods for
estimating IBD all lead to the same conclusion.
Discussion
The hypothesis that consanguineous couples with an af-
fected child have, on average, a higher amount of DNA
IBD than consanguineous couples with only healthy
children was not confirmed by this study. For clinical
purposes determining the amount of DNA IBD can,
therefore, not differentiate between consanguineous
couples at high risk vs. those at low risk. Results from
PLINK and IBDelphi show that both case couples and
control couples share on average more DNA IBD thanTable 5 Results of Mann Whitney test Tunisian subpopulation for ra
Mean / Median
Case
PLINK (by population) 0.132 / 0.073
King homo (by population) −0.529 / -0.520
IBDelphi 0.275 / 0.165
a Only measures by population are presented given the relative homogeneity of thexpected based on the pedigree. The same results ap-
plied to both first cousins and consanguineous couples
all combined. This is a phenomenon more often found es-
pecially in populations with a tradition of consanguinity,
where the proportion of DNA IBD is larger due to hidden
consanguineous loops in the extended family [11]. More-
over, extended tracts of homozygosity have been found
more generally in populations not even associated with re-
cent consanguinity [12–15].
In this study we have ascertained cases and controls
from a population at increased risk, namely consanguin-
eous couples. The exact magnitude of DNA IBD does
not seem to make any difference between the couples
who did have an affected child – and were thus revealed
as carriers of the same pathogenic mutation – and those
who had only healthy children. Chance plays a role in
the passing of parental mutations to the next generation,
and thus in having two pathogenic mutations in a child.
It is possible that our selection of couples contained con-
trol couples who, in reality, are carrier couples for the
same pathogenic mutation but have had only healthy chil-
dren. However, the chance of being a couple without a
similar pathogenic mutation is a priori already high. For
first cousins this is approximately 88.8-93.2 % (100 %
minus four times the risk for first cousins (1.7 – 2.8 %),
for second cousins 97.2-98.4 % as their risk is four times
lower than the risk for first cousins [3, 16]. Only couplestio Ra
Mann Whitney test
Control p-value
0.510 / 0.182 0.990
−0.372 / -0.440 0.982
0.426 / 0.165 0.815
e sample
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chances even more), leading to a small differentiation in a
posteriori chances between the different numbers of
healthy children. It was therefore decided not to apply
weighting according to the number of children.
In order to answer our research question, we performed
one-sided tests rather than two-sided tests, since it was hy-
pothesized that case couples have more DNA IBD than
control couples. From the values of the means and medians
as well as from the estimate of the regression parameter in
the (mixed) regression model, we see an opposite effect in
our data: the control couples have more DNA IBD than ex-
pected based on their kinship coefficient than the couples
with an affected child. This could be due to recall bias
where control couples may have reported less consanguin-
eous relationships in the family than case couples who were
counselled in clinical genetic centres because of their af-
fected child or children. Case couples may have made more
effort earlier when confronted with the autosomal recessive
disorder of their child to report the family history and fam-
ily loops, resulting in more awareness regarding consan-
guinity in their family. This may have led to a relatively
lower Rped for controls and thus a higher ratio R. Another
explanation could be the fact that control couples origi-
nated from more endogamous subpopulations, but this
would only serve as a possible explanation in, for example,
the Tunisian population, and not in the Saudi population
(where most control couples were from the same family). If
the trend towards controls sharing at least as much DNA
IBD as cases is in fact a real finding, more research is
needed to look into possible explanations, like differences
in the nature of the shared segments. Genes are unequally
distributed throughout the genome [17, 18] and consan-
guineous couples can as a result inherit more or less ‘quiet’
regions.
This study has several limitations. Although the initial
goal was to ascertain an intrafamilial control for every
case couple, the lack of available and suitable candidates
eventually resulted in only 10 cases for which this was
achieved.
In our power calculation we reasoned as follows: we as-
sumed that for first-cousin couples, who theoretically have
0.125 of their genome IBD, a standard deviation of 0.0625
would apply, and we expected to have sufficient power
(90 %) with 100 cases and 100 controls, counting a possible
loss of 15 %. However, ascertainment was difficult and the
sample turned out rather heterogeneous. Eventually, we
found 73 versus 78 couples instead of the 85 vs. 85 that we
anticipated. The results do not imply that a lack of power
in our study was the reason for not being able to confirm
our hypothesis. Therefore, including more couples will not
likely lead to a considerable effect size and a possible clin-
ical application of estimating DNA IBD in consanguineous
couples.Estimating relatedness coefficients is known to be com-
plicated, especially in the case of population stratification
and/or inbreeding [8, 19]. Our sample contains a variety of
ethnicities and individuals from populations with a trad-
ition of consanguinity. The heterogeneity of the sample
might be causing inflated estimates of kinship coefficients
due to population stratification. Because of the heterogen-
eity of the sample, SNPs with a relative lower frequency in
the sample, will be assigned an IBD status sooner than
might have happened if the whole sample was from the
same population. However, this principle applies to both
the case and the control group. Moreover, the three differ-
ent estimators were consistent in not showing that cases
share more DNA IBD than controls. The IBD estimation
in the overall analysis might also be inflated compared to
the actual IBD value because of the relative homogeneity
of the Saudi group versus the non-Saudi group. However,
both the IBDelphi approach and the separate population
approach were not influenced by the differences in the ap-
plied marker sets and they show comparable results.Conclusion
In this study, consanguineous partners that have a child
with an AR condition and most often are both carrier of
the same mutation for an AR disorder, do not share
more DNA IBD than similarly related consanguineous
couples that do not show evidence of carrier status of an
AR disorder. In order to assess the risk for a consan-
guineous couple in clinical practice in the preconception
phase, measuring the amount of DNA IBD does not
seem to be an effective approach. Further research on
other genomic techniques to improve risk assessment
for consanguineous couples is needed as current ap-
proaches are often unable to identify couples at high risk
of having affected children [3]. A promising possibility
may be the application of exome sequencing in the pre-
conception phase, although there are still many challenges
to face, like dealing with variants of unknown significance
or mutations that reside in the uncovered regions by ex-
ome sequencing [20, 21]. Whether preconceptional carrier
testing for a number of AR disorders, by tailor-made ana-
lysis for a panel of disorders for the population from
which the couple originates, is a less expensive alternative
and thus more feasible, remains to be seen.Additional file
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